logo
Select company
Select metric
-125.62%Operating Cash Flow Margin
VS
Market
10
Sector
35
Industry
65
History
100
$ 2.32Close
$ 1.66 - $ 12.28 52-Week Range
Ticker Information

Ticker

IOVA

Company Name

IOVANCE BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IOVANCE BIOTHERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IOVA - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -303.41M-125.62%$ 241.53M
3/31/2025$ -334.39M-157.23%$ 212.68M
12/31/2024$ -352.98M-215.14%$ 164.07M
9/30/2024$ -363.65M-400.24%$ 90.86M
6/30/2024$ -388.76M-1186.26%$ 32.77M
3/31/2024$ -384.28M-20182.98%$ 1.9M
12/31/2023$ -361.82M-30430.61%$ 1.19M
9/30/2023$ -355.52M-50285.86%$ 707K
6/30/2023$ -335.09M-140792.86%$ 238K
3/31/2023$ -318.77M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IOVANCE BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at 0%.
  • Over the past 5 years, IOVANCE BIOTHERAPEUTICS INC's average OCF % has been -27086.31%.
  • The median OCF % for IOVANCE BIOTHERAPEUTICS INC during this period was -1186.26%
  • IOVANCE BIOTHERAPEUTICS INC reached its highest OCF % over the past 5 years at -125.62%.
  • The lowest OCF % recorded by IOVANCE BIOTHERAPEUTICS INC in the same timeframe -140792.86%

IOVANCE BIOTHERAPEUTICS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
XERS : XERIS BIOPHARMA HOLDINGS INC -6.58%RCUS : ARCUS BIOSCIENCES INC -129.39%DNA : GINKGO BIOWORKS HOLDINGS INC -102.99%AKBA : AKEBIA THERAPEUTICS INC -1.18%AUPH : AURINIA PHARMACEUTICALS INC 35.63%MNKD : MANNKIND CORP 11.45%GERN : GERON CORP -108.41%STOK : STOKE THERAPEUTICS INC 30.81%KROS : KEROS THERAPEUTICS INC 23.64%DAWN : DAY ONE BIOPHARMACEUTICALS INC -33.61%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for IOVANCE BIOTHERAPEUTICS INC is calculated as follows: CF - Operations [ $ -196.26M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]

IOVA - Operating Cash Flow Margin, Last 5 years

-140792.86%

Minimum

Jun 30, 2023

-125.62%

Maximum

Jun 30, 2025

-27086.31%

Average

-1186.26%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max77.08%
average14.31%
median12.65%
std21.13%